Learn about:
- The shift in understanding of the contemporary etiology of pressure injury development
- How Bruin Biometrics identified a key biomarker that can now be measured and monitored
- Importance of treating the earliest signs of pressure injury development with existing equipment
- Impact for dark skin tone patients as the device “doesn’t see the skin color”
- The care enhancement for end-of-life patients
- How adoption is rapidly expanding across the US and Canada
- The full suite of data and evidence supporting that adoption
You can also listen to the full podcast through the following links: